Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 154
9
Diseases
37
Unique genes
0.026
Avg. similarity score
Glycogen storage disease
Most-connected disease (8 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Glycogen storage disease
Danon disease
Dimauro disease
PGM1-congenital disorder of glycosylation
glycogen storage disease III
glycogen storage disease V
glycogen storage disease VI
glycogen storage disease due to muscle and heart glycogen synthase deficiency
polyglucosan body myopathy type 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Glycogen storage disease | 8 | 8 | 37 |
| Danon disease | 1 | 1 | 1 |
| Dimauro disease | 1 | 1 | 1 |
| PGM1-congenital disorder of glycosylation | 1 | 1 | 1 |
| glycogen storage disease III | 1 | 1 | 1 |
| glycogen storage disease V | 1 | 1 | 1 |
| glycogen storage disease VI | 1 | 1 | 1 |
| glycogen storage disease due to muscle and heart glycogen synthase deficiency | 1 | 1 | 1 |
| polyglucosan body myopathy type 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| AGL | 2 / 9 | Glycogen storage disease, glycogen storage disease III |
| GYG1 | 2 / 9 | Glycogen storage disease, polyglucosan body myopathy type 2 |
| GYS1 | 2 / 9 | Glycogen storage disease, glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| LAMP2 | 2 / 9 | Danon disease, Glycogen storage disease |
| PGAM2 | 2 / 9 | Dimauro disease, Glycogen storage disease |
| PGM1 | 2 / 9 | Glycogen storage disease, PGM1-congenital disorder of glycosylation |
| PYGL | 2 / 9 | Glycogen storage disease, glycogen storage disease VI |
| PYGM | 2 / 9 | Glycogen storage disease, glycogen storage disease V |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Glucagon signaling pathway | KEGG | 16 / 107 | 48.5× | 5.42e-24 | 8.80e-21 ✓ sig. |
| Glycogen breakdown (glycogenolysis) | Reactome | 10 / 16 | 203× | 1.61e-22 | 2.09e-19 ✓ sig. |
| Starch and sucrose metabolism | KEGG | 10 / 36 | 90.2× | 4.90e-18 | 2.83e-15 ✓ sig. |
| Insulin signaling pathway | KEGG | 12 / 138 | 28.2× | 4.73e-15 | 1.60e-12 ✓ sig. |
| Glycolysis / Gluconeogenesis | KEGG | 9 / 67 | 43.6× | 3.30e-13 | 7.70e-11 ✓ sig. |
| Glycogen synthesis | Reactome | 5 / 16 | 101× | 8.93e-10 | 1.02e-7 ✓ sig. |
| Insulin resistance | KEGG | 8 / 109 | 23.8× | 1.10e-9 | 1.23e-7 ✓ sig. |
| Glycolysis | Reactome | 5 / 28 | 58.0× | 1.96e-8 | 1.57e-6 ✓ sig. |
| Metabolic pathways | KEGG | 19 / 1,563 | 3.9× | 2.30e-8 | 1.83e-6 ✓ sig. |
| HIF-1 signaling pathway | KEGG | 7 / 110 | 20.7× | 3.66e-8 | 2.71e-6 ✓ sig. |
| Gluconeogenesis | Reactome | 5 / 34 | 47.7× | 5.47e-8 | 3.86e-6 ✓ sig. |
| Central carbon metabolism in cancer | KEGG | 6 / 71 | 27.4× | 6.92e-8 | 4.76e-6 ✓ sig. |
| Biosynthesis of amino acids | KEGG | 6 / 75 | 26.0× | 9.65e-8 | 6.33e-6 ✓ sig. |
| AMPK signaling pathway | KEGG | 6 / 122 | 16.0× | 1.75e-6 | 7.84e-5 ✓ sig. |
| Galactose metabolism | KEGG | 4 / 32 | 40.6× | 2.58e-6 | 1.10e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| glycogen metabolic process | GO:0005977 | 13 / 40 | 164× | 7.66e-27 | 2.91e-23 ✓ sig. |
| glycogen catabolic process | GO:0005980 | 7 / 11 | 321× | 2.14e-17 | 2.36e-14 ✓ sig. |
| carbohydrate metabolic process | GO:0005975 | 11 / 175 | 31.7× | 2.45e-14 | 1.49e-11 ✓ sig. |
| glycolytic process | GO:0006096 | 7 / 49 | 72.2× | 5.29e-12 | 2.07e-9 ✓ sig. |
| glycogen biosynthetic process | GO:0005978 | 5 / 18 | 140× | 1.93e-10 | 5.18e-8 ✓ sig. |
| gluconeogenesis | GO:0006094 | 6 / 56 | 54.1× | 1.19e-9 | 2.62e-7 ✓ sig. |
| generation of precursor metabolites and energy | GO:0006091 | 5 / 49 | 51.5× | 4.11e-8 | 5.75e-6 ✓ sig. |
| canonical glycolysis | GO:0061621 | 4 / 22 | 91.8× | 9.27e-8 | 1.13e-5 ✓ sig. |
| striated muscle contraction | GO:0006941 | 4 / 24 | 84.2× | 1.34e-7 | 1.55e-5 ✓ sig. |
| muscle cell cellular homeostasis | GO:0046716 | 4 / 26 | 77.7× | 1.88e-7 | 2.06e-5 ✓ sig. |
| glucose metabolic process | GO:0006006 | 4 / 66 | 30.6× | 8.59e-6 | 4.63e-4 ✓ sig. |
| positive regulation of glycogen catabolic process | GO:0045819 | 2 / 4 | 253× | 2.28e-5 | 9.94e-4 ✓ sig. |
| glucose-6-phosphate transport | GO:0015760 | 2 / 7 | 144× | 7.96e-5 | 2.55e-3 ✓ sig. |
| cardiac muscle contraction | GO:0060048 | 3 / 43 | 35.2× | 8.35e-5 | 2.64e-3 ✓ sig. |
| fructose 1,6-bisphosphate metabolic process | GO:0030388 | 2 / 8 | 126× | 1.06e-4 | 3.16e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Danon disease | Glycogen storage disease | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Dimauro disease | Glycogen storage disease | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Glycogen storage disease | glycogen storage disease due to muscle and heart glycogen synthase deficiency | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Glycogen storage disease | glycogen storage disease III | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Glycogen storage disease | glycogen storage disease V | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Glycogen storage disease | glycogen storage disease VI | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Glycogen storage disease | PGM1-congenital disorder of glycosylation | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |
| Glycogen storage disease | polyglucosan body myopathy type 2 | 0.026 | 1 | 2.40e-3 | 3.30e-3 ✓ sig. |